Study of the Metabolism of Danicopan in Healthy Adults
Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This is a 2-part open-label, randomized, single-dose, 3-sequence, 3-period crossover,
relative bioavailability, and food-effect study comparing different formulations of danicopan
in healthy adult participants.